{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:45:46Z","timestamp":1783467946225,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05784-1","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:09:25Z","timestamp":1773133765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Class-Specific Antihypertensives and Alzheimer\u2019s Disease: Genotype- and Hypertension-Stratified Analysis"],"prefix":"10.1007","volume":"63","author":[{"given":"Dehao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"5784_CR1","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1038\/s41591-025-03616-8","volume":"31","author":"J He","year":"2025","unstructured":"He J, Zhao C, Zhong S, Ouyang N, Sun G, Qiao L et al (2025) Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial. Nat Med 31:2054\u20132061","journal-title":"Nat Med"},{"key":"5784_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jama.2018.21442","volume":"321","author":"JD Williamson","year":"2019","unstructured":"Group SMIftSR, Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G et al (2019) Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA 321:553\u2013561","journal-title":"JAMA"},{"key":"5784_CR3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1097\/EDE.0000000000001245","volume":"31","author":"VM Walker","year":"2020","unstructured":"Walker VM, Davies NM, Martin RM, Kehoe PG (2020) Comparison of antihypertensive drug classes for dementia prevention. Epidemiology 31:852\u2013859","journal-title":"Epidemiology"},{"key":"5784_CR4","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1002\/alz.13062","volume":"19","author":"M Nassan","year":"2023","unstructured":"Nassan M, Daghlas I, Piras IS, Rogalski E, Reus LM, Pijnenburg Y et al (2023) Evaluating the association between genetically proxied ACE inhibition and dementias. Alzheimers Dement 19:3894\u20133901","journal-title":"Alzheimers Dement"},{"key":"5784_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03760-x","volume":"22","author":"B Fan","year":"2024","unstructured":"Fan B, Zhang J, Zhao JV (2024) Systematic review of Mendelian randomization studies on antihypertensive drugs. BMC Med 22:547","journal-title":"BMC Med"},{"key":"5784_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A et al (2020) APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 581:71\u201376","journal-title":"Nature"},{"key":"5784_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10654-024-01194-6","volume":"40","author":"S Gutierrez","year":"2025","unstructured":"Gutierrez S, Glymour MM, Smith GD (2025) Evidence triangulation in health research. Eur J Epidemiol 40:743\u2013757","journal-title":"Eur J Epidemiol"},{"key":"5784_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01671-4","volume":"17","author":"H Zheng","year":"2025","unstructured":"Zheng H, Chen C, Feng Y (2025) Association of antihypertensive drug target genes with Alzheimer\u2019s disease: a mendelian randomization study. Alzheimers Res Ther 17:18","journal-title":"Alzheimers Res Ther"},{"key":"5784_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","volume":"19","author":"J Ding","year":"2020","unstructured":"Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C et al (2020) Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol 19:61\u201370","journal-title":"Lancet Neurol"},{"key":"5784_CR10","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1161\/HYPERTENSIONAHA.122.19378","volume":"79","author":"Z Deng","year":"2022","unstructured":"Deng Z, Jiang J, Wang J, Pan D, Zhu Y, Li H et al (2022) Angiotensin receptor blockers are associated with a lower risk of progression from mild cognitive impairment to dementia. Hypertension 79:2159\u20132169","journal-title":"Hypertension"},{"key":"5784_CR11","doi-asserted-by":"crossref","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafo MR et al (2022) Mendelian randomization. Nat Rev Methods Primers 2","DOI":"10.1038\/s43586-021-00092-5"},{"key":"5784_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt AF, Finan C, Gordillo-Maranon M, Asselbergs FW, Freitag DF, Patel RS et al (2020) Genetic drug target validation using Mendelian randomisation. Nat Commun 11:3255","journal-title":"Nat Commun"},{"key":"5784_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040980","author":"BA Ference","year":"2021","unstructured":"Ference BA, Holmes MV, Smith GD (2021) Using Mendelian randomization to improve the design of randomized trials. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a040980","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5784_CR14","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA et al (2021) Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR Statement. JAMA 326:1614\u20131621","journal-title":"JAMA"},{"key":"5784_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM et al (2019) Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res 4:186","journal-title":"Wellcome Open Res"},{"key":"5784_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G (2017) Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet 13:e1007081","journal-title":"PLoS Genet"},{"key":"5784_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512\u2013525","journal-title":"Int J Epidemiol"},{"key":"5784_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40:304\u2013314","journal-title":"Genet Epidemiol"},{"key":"5784_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/alz.12422","volume":"18","author":"DP Veitch","year":"2022","unstructured":"Veitch DP, Weiner MW, Aisen PS, Beckett LA, DeCarli C, Green RC et al (2022) Using the Alzheimer\u2019s disease neuroimaging initiative to improve early detection, diagnosis, and treatment of Alzheimer\u2019s disease. Alzheimers Dement 18:824\u2013857","journal-title":"Alzheimers Dement"},{"key":"5784_CR20","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A et al (2023) 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 41:1874\u20132071","journal-title":"J Hypertens"},{"key":"5784_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10654-020-00659-8","volume":"35","author":"BA Dickerman","year":"2020","unstructured":"Dickerman BA, Hernan MA (2020) Counterfactual prediction is not only for causal inference. Eur J Epidemiol 35:615\u2013617","journal-title":"Eur J Epidemiol"},{"key":"5784_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/cpt.70150","volume":"119","author":"EA Jafari","year":"2026","unstructured":"Jafari EA, Alshahawey M, Zaman MA, Smith SM, Gong Y, Smith GE et al (2026) Characterizing Alzheimer\u2019s disease and related dementia in a hypertension population within the State of Florida using electronic health record-based data. Clin Pharmacol Ther 119:751\u2013762","journal-title":"Clin Pharmacol Ther"},{"key":"5784_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41440-025-02417-3","volume":"49","author":"M Mogi","year":"2026","unstructured":"Mogi M, Takami Y, Ihara M, Yamashita T, Takeda S, Shibata S et al (2026) Current updates on latest basic research of scientific relevance in hypertensive dementia. Hypertens Res 49:237\u2013271","journal-title":"Hypertens Res"},{"key":"5784_CR24","doi-asserted-by":"crossref","unstructured":"Cheung ECL, Adesuyan M, Szilcz M, Kalisch Ellett LM, Shah S, Jani YH et al (2025) Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study. Age Ageing 54","DOI":"10.1093\/ageing\/afaf121"},{"key":"5784_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105378","volume":"109","author":"SK Lundin","year":"2024","unstructured":"Lundin SK, Hu X, Feng J, Lundin KK, Li L, Chen Y et al (2024) Association between risk of Alzheimer\u2019s disease and related dementias and angiotensin receptor \u2161 blockers treatment for individuals with hypertension in high-volume claims data. EBioMedicine 109:105378","journal-title":"EBioMedicine"},{"key":"5784_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/alz.12680","volume":"19","author":"TJ Littlejohns","year":"2023","unstructured":"Littlejohns TJ, Collister JA, Liu X, Clifton L, Tapela NM, Hunter DJ (2023) Hypertension, a dementia polygenic risk score, APOE genotype, and incident dementia. Alzheimers Dement 19:467\u2013476","journal-title":"Alzheimers Dement"},{"key":"5784_CR27","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3233\/JAD-171119","volume":"62","author":"PG Kehoe","year":"2018","unstructured":"Kehoe PG (2018) The coming of age of the angiotensin hypothesis in Alzheimer\u2019s disease: progress toward disease prevention and treatment? J Alzheimers Dis 62:1443\u20131466","journal-title":"J Alzheimers Dis"},{"key":"5784_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3233\/JAD-2009-1002","volume":"16","author":"ER Vardy","year":"2009","unstructured":"Vardy ER, Rice PJ, Bowie PC, Holmes JD, Catto AJ, Hooper NM (2009) Plasma angiotensin-converting enzyme in Alzheimer\u2019s disease. J Alzheimers Dis 16:609\u2013618","journal-title":"J Alzheimers Dis"},{"key":"5784_CR29","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/hmg\/ddg094","volume":"12","author":"PG Kehoe","year":"2003","unstructured":"Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B et al (2003) Haplotypes extending across ACE are associated with Alzheimer\u2019s disease. Hum Mol Genet 12:859\u2013867","journal-title":"Hum Mol Genet"},{"key":"5784_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105515","volume":"166","author":"L Scotti","year":"2021","unstructured":"Scotti L, Bassi L, Soranna D, Verde F, Silani V, Torsello A et al (2021) Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: a meta-analysis. Pharmacol Res 166:105515","journal-title":"Pharmacol Res"},{"key":"5784_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28145481","author":"M Colin","year":"2023","unstructured":"Colin M, Delaitre C, Foulquier S, Dupuis F (2023) The AT(1)\/AT(2) receptor equilibrium is a cornerstone of the regulation of the renin angiotensin system beyond the cardiovascular system. Molecules. https:\/\/doi.org\/10.3390\/molecules28145481","journal-title":"Molecules"},{"key":"5784_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00778-8","volume":"13","author":"M Ouk","year":"2021","unstructured":"Ouk M, Wu CY, Rabin JS, Jackson A, Edwards JD, Ramirez J (2021) The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer\u2019s disease: the importance of blood-brain barrier penetration and APOE epsilon4 carrier status. Alzheimers Res Ther 13:43","journal-title":"Alzheimers Res Ther"},{"key":"5784_CR33","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1002\/alz.12624","volume":"18","author":"J Levin","year":"2022","unstructured":"Levin J, Voglein J, Quiroz YT, Bateman RJ, Ghisays V, Lopera F et al (2022) Testing the amyloid cascade hypothesis: prevention trials in autosomal dominant Alzheimer disease. Alzheimers Dement 18:2687\u20132698","journal-title":"Alzheimers Dement"},{"key":"5784_CR34","doi-asserted-by":"crossref","unstructured":"Munafo MR, Higgins JPT, Smith GD (2021) Triangulating evidence through the inclusion of genetically informed designs. Cold Spring Harb Perspect Med 11","DOI":"10.1101\/cshperspect.a040659"},{"key":"5784_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00843-y","volume":"20","author":"AA Belaidi","year":"2025","unstructured":"Belaidi AA, Bush AI, Ayton S (2025) Apolipoprotein E in Alzheimer\u2019s disease: molecular insights and therapeutic opportunities. Mol Neurodegener 20:47","journal-title":"Mol Neurodegener"},{"key":"5784_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.14283\/jpad.2022.77","volume":"9","author":"M Adesuyan","year":"2022","unstructured":"Adesuyan M, Jani YH, Alsugeir D, Cheung ECL, Chui CSL, Howard R et al (2022) Antihypertensive agents and incident Alzheimer\u2019s disease: a systematic review and meta-analysis of observational studies. J Prev Alzheimers Dis 9:715\u2013724","journal-title":"J Prev Alzheimers Dis"},{"key":"5784_CR37","doi-asserted-by":"crossref","unstructured":"Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. Bmj","DOI":"10.1136\/bmj.k601"},{"key":"5784_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133\u2013150","journal-title":"Nat Rev Neurol"},{"key":"5784_CR39","doi-asserted-by":"crossref","unstructured":"Noureddine FY, Altara R, Fan F, Yabluchanskiy A, Booz GW, Zouein FA (2020) Impact of the renin-angiotensin system on the endothelium in vascular dementia: unresolved issues and future perspectives. Int J Mol Sci 21","DOI":"10.3390\/ijms21124268"},{"key":"5784_CR40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P (2017) Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med 167:268\u2013274","journal-title":"Ann Intern Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05784-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05784-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05784-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:09:31Z","timestamp":1773133771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05784-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5784"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05784-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study utilized data from the publicly available Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) database. As the data are de-identified and publicly, obtaining informed consent from individual participants was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"492"}}